4 / 79
6TH ICHNO CONTENT
THURSDAY 16 MARCH 2017
Keynote lecture
Immunotherapy for head and neck cancer: integrating the fourth modality....................................Abs. 1
State of the art in robotic surgery ...........................................................................................Abs. 2
Symposium
Prognostic modelling.......................................................................................................... Abs. 3-5
Proffered papers
Proffered papers 1............................................................................................................. Abs. 6-9
Randomised trials
New data from randomised trials . .................................................................................... Abs. 10-13
Symposium
Reductions of radiation induced toxicities .......................................................................... Abs. 14-16
FRIDAY 17 MARCH 2017
Keynote lecture
New imaging techniques ......................................................................................................Abs. 17
HNC Biomarkers - how do we translate biology into useful assays for clinical care? . .....................Abs. 18
Proffered papers
Proffered papers 2......................................................................................................... Abs. 19-22
Symposium
New developments in surgery.......................................................................................... Abs. 23-25
Interactive tumour board session
Limited T4a larynx cancer
Poster discussion
Poster discussion ........................................................................................................... Abs. 26-34
Symposium
New developments in systemic treatment . ........................................................................ Abs. 35-37
SATURDAY 18 MARS 2017
Keynote lecture
Clinical implementation of adaptive radiotherapy: challenges ahead ...........................................Abs. 38
Symposium
Adenoid cystic carcinoma ................................................................................................ Abs. 39-40
Proffered papers
Proffered papers 3 ......................................................................................................... Abs. 42-45
Debate
Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore . ..... Abs. 46-49
Conference remarks
Concluding remarks
Posters
Multidisciplinary management . ........................................................................................ Abs. 50-76
Innovative treatments .................................................................................................... Abs. 78-96
Biology, HPV and molecular targeting . ............................................................................ Abs. 97-108
Imaging and radiomics ................................................................................................Abs. 109-116
Supportive care, quality of life, rehabilitation ..................................................................Abs. 117-130
Minimal invasive and reconstructive surgery ...................................................................Abs. 131-134
Epidemiology and prevention . ......................................................................................Abs. 135-137
Salivary gland, skull base, skin and thyroid cancers .........................................................Abs. 138-143
Special requirements for elderly patients . ......................................................................Abs. 144-150
Immunodiagnosis and immunotherapy ................................................................................. Abs. 151
AUTHOR INDEX ....................................................................................................................
page 74